M Yoshinari Selected Research

M Yoshinari Research Topics

2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2005 - 06/2000
2	Acute Promyelocytic Leukemia 12/2001 - 02/2001
2	Diabetes Mellitus 05/2001 - 11/2000
1	Urticaria (Hives) 05/2015
1	Fatigue 08/2012
1	Azoospermia 05/2005
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2005
1	Osteoporosis 07/2002
1	Hypercalcemia (Milk Alkali Syndrome) 12/2001
1	Hypoglycemia (Reactive Hypoglycemia) 06/2001
1	Hyperglycemia 06/2001
1	AIDS-Related Complex (ARC) 03/2001
1	Residual Neoplasm 02/2001
1	Ketosis 11/2000
1	Type 2 Diabetes Mellitus (MODY) 10/2000
1	Hypertriglyceridemia 09/2000
1	Body Weight (Weight, Body) 09/2000
1	Obesity 09/2000
1	Hypersensitivity (Allergy) 03/2000
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2000
1	Atrophy 02/2000
1	Normal Pressure Hydrocephalus 02/2000
1	Coma (Comas) 02/2000

2	Diphosphonates (Bisphosphonates)IBA 07/2002 - 12/2001
2	Insulin (Novolin)FDA Link 06/2001 - 11/2000
1	AutoantibodiesIBA 05/2015
1	Thyroid HormonesIBA 05/2015
1	Dental Implants (Dental Implant)IBA 08/2012
1	AcidsIBA 08/2012
1	MEF2 Transcription FactorsIBA 05/2005
1	Proteins (Proteins, Gene)FDA Link 05/2005
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2005
1	Prostaglandins EIBA 01/2005
1	Superoxides (Superoxide)IBA 01/2005
1	AntioxidantsIBA 01/2005
1	Deferoxamine (Desferal)FDA LinkGeneric 01/2005
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2001
1	methylatropineIBA 06/2001
1	Cholinergic Agents (Cholinergics)IBA 06/2001
1	Mitochondrial DNA (mtDNA)IBA 05/2001
1	ArgonIBA 03/2001
1	promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA 02/2001
1	Retinoic Acid Receptor alphaIBA 02/2001
1	Enalapril FDA LinkGeneric 10/2000
1	Nicardipine (Dagan)FDA LinkGeneric 10/2000
1	Endothelin-1 (Endothelin 1)IBA 10/2000
1	LeptinIBA 09/2000
1	Sodium Glutamate (Accent)IBA 09/2000
1	PPAR gammaIBA 06/2000
1	ThiazolidinedionesIBA 06/2000
1	LigandsIBA 06/2000
1	Blood Glucose (Blood Sugar)IBA 06/2000
1	Rubber (Elastica)IBA 03/2000
1	LatexIBA 03/2000
1	Hypoglycemic Agents (Hypoglycemics)IBA 02/2000

3	Therapeutics 01/2005 - 11/2000
1	Microspheres (Microsphere) 06/2001